We tested the hypothesis that, the red blood cell (RBC) mass, estimated by hematocrit (HCT) or hemoglobin (Hb) level, influences the carbon monoxide (CO) production rate.
INTRODUCTION
Carbon monoxide (CO) generated in the body originates mainly from heme degradation. Consequently, CO production is significantly increased when hemolysis occurs in premature as well as in full-term infants. 1, 2 Recently, The American Academy of Pediatrics recommended the measurement of end tidal CO (ETCOc) as the only test that provides a direct measurement of heme catabolism and bilirubin production rate. 3 Compared to older infants, neonates experience an increased rate of red blood cell (RBC) breakdown, even in the absence of any special hemolytic process, because of a combination of two factors: the first one is the increased red blood cell mass present at birth and shorter life span of fetal RBC. 4 Furthermore, there are very large variations in the RBC mass at birth, with normal hemoglobin (Hb) concentrations values varying between 14.9 and 23.7g/dl, with corresponding normal capillary hematocrit (HCT) values varying between 0.46 and 0.76. 5 CO generation varies according to heme degradation. Thus, it is likely that the amount of CO generated is affected by the initial RBC mass.
We therefore conducted the present study in order to test the hypothesis that in normal neonates, CO production, estimated by corrected end tidal CO (ETCO C ), correlates with estimates of RBC mass such as HCT level or Hb concentration.
METHODS

Patients
This prospective, observational study was conducted during the month of December 2003, among newborn infants consecutively admitted to the well baby nursery at the Lis Maternity Hospital. Only healthy infants, appropriate for gestational age, delivered between 37 and 42 weeks of gestation were eligible for inclusion in the study. We carefully excluded all infants with, or at high risk for hemolysis, that is, those with reticulocyte count above >5%, those with glucose-6-phosphate dehydrogenase (G6PD) deficiency, or those born to mothers of group O or Rh negative. In addition, we excluded infants with extensive bruising or closed space hemorrhage such as cephalohematoma detected by physical examination performed prior to their inclusion in the study group, as well as babies of mothers who reported smoking or exposure to passive smoking shortly before delivery.
Laboratory Methods
Per departmental protocol, all infants admitted to the normal newborn nursery undergo a routine complete blood count (CBC) for the screening of polycythemia. This CBC is obtained from a warmed heel capillary sample within the first 2 hours of birth, using an GEN-S counter (Beckman-Coulter Inc. Switzerland) STK-S counter (Coulter Corporation, Hialeah, FL, USA).
In our institution universal screening for G6PD deficiency is performed using a quantitative colorimetric method of reduction of NADPH þ (Sentinel CH. Milan, Italy). 6 The ETCOc measurement was performed using the Everest COCO 2 puff breath analyzer (Everest Biomedical Instruments Company Chesterfield, MO, USA). The accuracy of the analyzer is ±0.3 ppm or 10% of the reading at 8 to 80 ppm and the resolution is 0.1 ppm. In our hands the reproducibility and the coefficient of variation of the analyzer is 9%. The instrument automatically measures samples of exhaled air, using a 5F catheter inserted 2 to 3 mm into the baby's nostril. Once a repeatable breath rate has been observed, the device continues sampling until an acceptable end tidal sample has been detected. The sample is analyzed by an electrochemical sensor. It is calibrated against a zero CO gas as well as a standard CO gas. In addition to ETCO measurement, the instrument measures also the ambient (room air) CO concentration, so the final results are expressed as ETCOc (ETCO corrected for the ambient CO concentration). Each infant had three consecutive measurements. The final ETCOc result was calculated as the mean value of the two closest results (out of three). The tests were performed while the infants breathed quietly, usually during sleep, or pacified by a pacifier. All the infants were checked usually before they received their first meal, except for a few who breast-fed in the delivery room.
This study was approved by our local Institutional review board, and informed consent was obtained from one of each participant's parents.
Data Analysis
Demograhic data, HCT and Hb concentration and ETCOc are reported as mean±standard deviation (SD) or median (range). We also calculated the index ETCOc/HCT in order to ''correct'' values of ETCOc for HCT levels. Analyses were conducted using Minitab Version 9.2 software, (Minitab Inc. State College, PA, USA). Statistical analysis included best fit regression to test the relationship between ETCOc measurements and the HCT (or the Hb concentration) and Student t test in order to compare ETCOc in infants with high capillary HCT level (>0.65) with those with lower HCT (<0.65). A p-value <0.05 was considered significant.
RESULTS
A total of 83 consecutive infants were eligible for the study. In all, 25 infants were excluded because of suspected or confirmed hemolytic processes (according with the above mentioned criteria), or because of maternal smoking. Thus, 58 infants remained in the final analyses. Five of them were delivered by cesarian section, one by vacuum extraction, all the others by spontaneous delivery. In total, 35 (42%) of the mothers delivered under epidural anesthesia. Except for four, all the mothers were healthy. The four mothers were diagnosed as following: one gestational diabetes, one appropriated treated for positive VDRL during pregnancy, one celiac disease and one developed urinary tract infection due to group B streptococcus. (Figure 1 ). Within the range of postnatal age studied (3 to 8 hours), there was no significant correlation between ETCOc and age at the time of sampling. In multiple regression analysis, the correlation between ETCOc and HCT remained significant even after taking into account the age at sampling.
Half of the studied infants (29) had capillary HCT above 65%. These infants had significantly higher ETCOc: mean (SD) 1.99 ppm (0.49) compared to those with capillary HCTs <65%: mean (SD)1.74 ppm (0.39), p ¼ 0.035. However, when the index ETCOc/HCT was used, there were no longer differences between the two groups: 2.96 (0.70), versus 2.79 (0.64), respectively, p ¼ 0.34. 
DISCUSSION
We have shown, as hypothesized, for the first time that, in a population of newborn infants ETCOc significantly correlated with Hb concentration or HCT level within the first 8 hours of life. In this study, CO production was estimated using the ETCOc measurement, that corrects the CO measured in exhaled air by taking into account ambient CO concentration. Our observation is of importance because of the fact that most studies that have attempted to examine endogenously produced carbon monoxide, as an index of hemolysis and bilirubin production, 1,2,7-12 did not take into account the HCT (a reliable estimate of red blood cell mass in hemodynamically stable individuals) as a significant confounding variable. In the early neonatal period, the influence of the initial RBC mass on CO generation may be even more significant. Indeed, the range of HCT values after birth is very wide: normal reported values for neonatal capillary HCT range from 46 to 76%. 5 Thus, normal variations in HCT have the potential of introducing a very large bias in ETCOc measurements. For instance, and as predicted by the regression line that was produced from our data, a variation in capillary HCT from the lowest normal reported value of 46% to highest one of 76% would increase ETCOc from a predicted value of 1.44 to a predicted value of 2.12, that is an increase of 47%. Once again, this ETCOc increase would be entirely explained by differences in HCT, without the contribution of any additional risk factors. When we used the ETCOc/HCT index, however, differences in ETCOc between infants with HCT >65% and those with lower one <0.65% were no longer present.
Theoretically, several factors may explain the power of RBC mass contribution to CO production in newborn infants, even in the absence of pathological hemolysis: fetal erythrocytes have a relative short life span of 70 to 90 days, compared to 120 days in adults. 4 Moreover, the increased RBC mass in neonates (due to a larger blood volume and a higher HCT than adults) contributes to higher substrate mass for CO production.
The finding that HCT influences ETCOc in normal neonates, may help bring a better understanding on the physiology of CO production. For example there is a progressive physiologic decline of ETCOc over the first week of life. 1, 4, 13 Notably, there is a parallel decline in the mean Hb concentration over the first week of life from 19.3 (2.2) to 17.9 (2.5) g/dl and in the mean HCT level from 61 (7.4) to 56 (9.4) (capillary samples). 5 We speculate that the reported decline of ETCOc might be related to the progressively decreasing mass of RBC breaking down over the first days after delivery; during that period, there is no compensatory increase in erythropoiesis, due to nearly undetectable erythropoietin concentrations in the first week of life. 14 Our findings may also help us better understand the observation by Bartoletti et al. 1 that polycythemic and small for gestational age infants have higher CO production than control infants. In their study, polycythemic and small for gestational age infants had a Hb concentration of 21 to 23 g/dl while control infants had a Hb level of 17.0 (2.0) g/dl. The difference observed in CO production (measured as pulmonary excretion of CO) between the two groups, although not statistically significant, may well have been in part explained by differences in HCT. Similarly, Stevenson et al. 2 described higher levels of CO production in infants of insulindependent diabetic mothers compared to controls, an observation that may well have been due to higher RBC mass, since this particular population of infants have increased HCT, as well as increased indices of RBC production. 15, 16 The mean ETCOc values of 1.88 ppm (0.46) found in our study were higher than those reported in previous studies:
2,10,17 1.48 ppm (0.49) and 1.3 ppm (0.7). Differences in equipment may be in part the reason for these differences. However, in our study, patients had a younger age at the time of the measurement: 5 hour (1.4) compared with 14 to 36 hours in the other studies. When tested within 12 hours of birth, very similar values of ETCOc have been found by others. 7, 8 Interestingly, we measured ETCOc at the peak HCT occurring at 4 to 6 hours of life, while others have examined ETCO at an age when HCT has already significantly declined. 18 Others and we have shown that at the time of the peak HCT, the rate of polycythemia, when defined as a venous HCT of 65%, is 20% in normal neonates. 18 In the current study, a significantly higher proportion of infants had a HCT higher than 65%, but this does not truly reflect a high incidence of polycythemia since blood was obtained from capillary samples, known to have a much higher HCT than venous samples. 5 The concept of using an index of CO production/total RBC mass has been already suggested by Hayde. 19 In their study carboxyhemoglobin/Hb index was used as an indicator for hemolysis and was found to correlate with bilirubin concentration in infants with hemolytic disease due to Rh incompatibility.
The use of the suggested index might add information about the mechanism of hyperbilirubinemia. In hemolytic anemic infants, this index will obviously be high due to the high rate of CO production together with the parallel decrease in RBC number. On the other hand, polycythemic infants might have higher CO production rate, which could be erroneously interpreted as sign of hemolysis. Thus, high values of uncorrected ETCOc in a baby with high Hb or Hct may imply that there is a high quantity of heme being catabolized with resultant bilirubin formation and high bilirubin load. In this case, the large amount of heme may be catabolized simply because of the greater Hb mass: the rate of heme catabolism may normal and not necessarily signify a pathological hemolytic process, but the baby may still be at high risk for hyperbilirubinemia. On the other hand, correction of ETCOc for Hb will facilitate differentiation of those with high ETCOc values between those catabolizing large amounts of heme but at the normal rate, from those with an abnormally increased rate of heme catabolism. 19, 20 In this situation those with a normal rate can be expected to have lower corrected ETCOc index values than those with an increased rate. Nonetheless, since from a therapeutic point of view the need for intervention is dictated by the bilirubin concentration, the ETCOc level per se, even uncorrected for HTC, remains an useful parameter, indicating bilirubin production rate.
In view of our results, it appears that in neonates carbon monoxide generation is significantly affected by the initial RBC mass. In order to correct for initial differences in RBC mass we suggest that the index of ETCOc/HCT might increase the sensitivity and the specificity of this methodology in predicting pathologic hemolysis.
